Robinson Value Management, Ltd. Abb Vie Inc. Transaction History

Robinson Value Management, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $2,041 - $2,582	-19 Reduced 0.38%	4,947 $670,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $2,021 - $2,294	19 Added 0.38%	4,966 $536,000
Q4 2020 Feb 19, 2021	SELL	$80.49 - $108.67 $84,755 - $114,429	-1,053 Reduced 17.55%	4,947 $530,000
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $19,972 - $25,529	-304 Reduced 4.82%	6,000 $436,000
Q1 2018 Apr 18, 2018	SELL	$92.01 - $123.21 $156,048 - $208,964	-1,696 Reduced 21.2%	6,304 $597,000
Q3 2017 Nov 16, 2017	BUY	$69.85 - $89.22 $558,800 - $713,760	8,000	8,000 $711,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Robinson Value Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Robinson Value Management, Ltd. with notifications on news.